Aeglea Biotherapeutics shares owned by Chartwell Investment Partners
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Chartwell Investment Partners
from 13F filings
Historical chart of Chartwell Investment Partners investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Chartwell Investment Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Aeglea Biotherapeutics by Chartwell Investment Partners
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $259k | 6.8k | 37.96 |
More positions owned by Chartwell Investment Partners
View all positions for Chartwell Investment Partners